Spironolactone and renin-angiotensin system drugs in heart failure: risk of potentially fatal hyperkalaemia—clarification, December 2016
In light of feedback, we have clarified our article on concomitant use of these medicines in heart failure.
Letters sent to healthcare professionals in November 2016
A summary of recent letters sent to relevant healthcare professionals, to inform them of updated safety information.
Cobicistat, ritonavir and coadministration with a steroid: risk of systemic corticosteroid adverse effects
Coadministration of a corticosteroid with an HIV-treatment-boosting agent may increase the risk of adrenal suppression due to a pharmacokinetic interaction.